Home | Welcome to Contract Pharma   
Last Updated Saturday, September 20 2014
Print RSS Feed

Breaking News

September 16, 2014
Gains exclusive rights to develop and commercialize products globally  Read More »
September 16, 2014
Johnson to oversee product safety and compliance  Read More »
September 16, 2014
To co-develop and commercialize BACE inhibitor, AZD3293  Read More »
September 16, 2014
Adds serialization for labeling and encoding, updates ops  Read More »
September 15, 2014
Ho to lead clinical development, regulatory and translational medicine functions  Read More »
September 15, 2014
India-based generic manufacturers to expand access to Hep C drugs  Read More »
September 15, 2014
Evotec to provide screening of compound libraries in multiple assay formats  Read More »
September 12, 2014
Aims to help pharma meet strict quality requirements  Read More »
September 12, 2014
Will leverage Evotec's high-throughput screening and proteomics platforms  Read More »
September 12, 2014
Aims to meet clinical development needs for all therapeutic areas  Read More »
September 11, 2014
Additional funding to support Phase II trial of CLT-008 in AML  Read More »
September 11, 2014
Will use MabVax platform to develop anti-cancer therapeutics  Read More »
September 11, 2014
Hantson named chief executive officer  Read More »
September 10, 2014
Aims to reduce costs, save time and enhance patient engagement  Read More »
September 10, 2014
Genmab to pay $11 million for exclusive rights to Seattle Genetics' ADC technology  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On